Page last updated: 2024-08-21

oxazoles and oritavancin

oxazoles has been researched along with oritavancin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strain, J1
Hussar, DA1
Burnham, CA; Crotty, MP; Krekel, T; Ritchie, DJ1
Bassetti, M; Concia, E; Cristini, F; De Rosa, FG; Esposito, S; Menichetti, F; Petrosillo, N; Russo, A; Tumbarello, M; Venditti, M; Viale, P; Viscoli, C1
Li, R; Nailor, MD1
Bridgeman, MB; Dalal, KS1

Reviews

2 review(s) available for oxazoles and oritavancin

ArticleYear
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
    Journal of clinical microbiology, 2016, Volume: 54, Issue:9

    Topics: Anti-Infective Agents; Drug Approval; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Teicoplanin; United States; Vancomycin-Resistant Enterococci

2016
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22 Suppl 2

    Topics: Ambulatory Care; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; United States; United States Food and Drug Administration

2016

Other Studies

4 other study(ies) available for oxazoles and oritavancin

ArticleYear
Three new agents added to the arsenal to fight MRSA.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2014, Volume: 67, Issue:12

    Topics: Anti-Bacterial Agents; Drug Approval; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Streptococcal Infections; Teicoplanin; United States; United States Food and Drug Administration

2014
New drugs 2015, part 2.
    Nursing, 2015, Volume: 45, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Benzofurans; Cyclopropanes; Diphosphates; Drug Approval; Drug Therapy; Glucagon-Like Peptide 1; Glucosides; Glycopeptides; Humans; Lactones; Lipoglycopeptides; Organophosphates; Oxazoles; Pyridines; Sulfates; Teicoplanin; United States; United States Food and Drug Administration

2015
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.
    Connecticut medicine, 2016, Volume: 80, Issue:3

    Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Costs and Cost Analysis; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Practice Guidelines as Topic; Skin Diseases, Bacterial; Teicoplanin; Treatment Outcome

2016
Antibiotics.
    Nursing, 2017, Volume: 47, Issue:3

    Topics: Acute Disease; Anti-Bacterial Agents; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Teicoplanin

2017